Shares of IDEXX Laboratories (NASDAQ: IDXX) were moving higher today after the veterinary healthcare company posted better-than-expected results in its third-quarter earnings but slashed its full-year earnings guidance due to the stronger dollar and higher interest rates.
As of 9:53 a.m. ET, the stock was up 9.9%.
The company said overall revenue was up 4% in the quarter to $841.7 million, but organic sales, which adjust for currency headwinds, increased 8%. That figure still beat analyst estimates at $830.8 million.
Source Fool.com